Antibody Therapies in Autoimmune Encephalitis

por Smets, I., Titulaer, M. J.
Publicado 2022

Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment

por Smets, I., Reyes, S., Baker, D., Giovannoni, G.
Publicado 2021

T1w/FLAIR ratio standardization as a myelin marker in MS patients

por Cappelle, S., Pareto, D., Sunaert, S., Smets, I., Laenen, A., Dubois, B., Demaerel, Ph.
Publicado 2022

Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis

por Allen-Philbey, K., Stennett, A., Begum, T., Johnson, AC., Dobson, R., Giovannoni, G., Gnanapavan, S., Marta, M., Smets, I., Turner, B.P., Baker, D., Mathews, J., Schmierer, K.
Publicado 2021

Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis

por Allen-Philbey, K., Stennett, A., Begum, T., Johnson, A.C., MacDougall, A., Green, S., Dobson, R., Giovannoni, G., Gnanapavan, S., Marta, M., Smets, I., Turner, B.P., Baker, D., Mathews, J., Schmierer, K.
Publicado 2022